Glucose-induced metabolic memory in Schwann cells: Prevention by PPAR agonists

Endocrinology

Volumn 154, Issue 9, 2013, Pages 3054-3066

  Kim, Esther S ^a   Isoda, Fumiko ^a   Kurland, Irwin ^b   Mobbs, Charles V ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DNA; FATTY ACID; FENOFIBRATE; GLUCOSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ARTICLE; CELL METABOLISM; CENTRAL NERVOUS SYSTEM; CHROMATIN IMMUNOPRECIPITATION; CITRIC ACID CYCLE; CPG ISLAND; DIABETES MELLITUS; DIABETIC NEUROPATHY; DNA METHYLATION; DRUG TARGETING; FATTY ACID METABOLISM; GENE EXPRESSION REGULATION; GENE MEMORY; GLUCOSE METABOLISM; GLYCOLYSIS; HYPERGLYCEMIA; MEMORY; METABOLIC MEMORY; METABOLIC PARAMETERS; METABOLIC REGULATION; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANIMALS; CELL LINE; CITRIC ACID CYCLE; DIABETIC NEUROPATHIES; DNA METHYLATION; ENERGY METABOLISM; FENOFIBRATE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE; GLYCOLYSIS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LIPID METABOLISM; MICE; MOLECULAR TARGETED THERAPY; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; PENTOSE PHOSPHATE PATHWAY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; SCHWANN CELLS;

EID: 84883150604     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1097     Document Type: Article

References (56)

1. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia. 2000;43(8):957-973.
2. Lehmann HC, Höke A. Schwann cells as a therapeutic target for peripheral neuropathies. CNS Neurol Disord Drug Targets. 2010; 9(6):801-806.
3. Vareniuk I, Pavlov IA, Obrosova IG. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes. Diabetologia. 2008;51(11):2126-2133.
4. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis. 1999;6(5):347-363.
5. Pop-Busui R, Sima A, StevensM.Diabetic neuropathy and oxidative stress. Diabetes/Metab Res Rev. 2006;22(4):257-273.
6. The Diabetes Control and Complications Trial ResearchGroup. med[b] The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med. 1995;122(8):561-568.
7. Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA. 2003;290(16):2159-2167.
8. Ihnat MA, Thorpe JE, Ceriello A. Hypothesis: the 'metabolic memory', the new challenge of diabetes. Diabet Med. 2007;24(6):582-586.
9. Roy S, Sala R, Cagliero E, Lorenzi M. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA. 1990;87(1):404-408.
10. KowluruRA,ZhongQ,KanwarM.Metabolicmemoryand diabetic retinopathy: role of inflammatory mediators in retinal pericytes. Exp Eye Res. 2010;90(5):617-623.
11. El-Osta A, Brasacchio D, Yao D, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J ExpMed. 2008;205(10):2409-2417.
12. Brasacchio D, Okabe J, Tikellis C, et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes. 2009;58(5):1229-1236.
13. Villeneuve LM, Reddy MA, Lanting LL, Wang M, Meng L, Natarajan R. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci USA. 2008;105(26):9047-9052.
14. Chaturvedi N. Metabolic memory in the autonomic neuropathy of diabetes: implications for pathogenesis and patient care. Circulation. 2009;119(22):2865-2867.
15. Pande M, Hur J, Hong Y, et al. Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes. Diabetes. 2011;60(7):1981-1989.
16. Hur J, Sullivan KA, Pande M, et al. The identification of gene expression profiles associated with progression of human diabetic neuropathy. Brain. 2011;134(Pt 11):3222-3235.
17. Saltiel AR, Olefsky JM. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes. 1996;45(12):1661-1669.
18. BellCG,Teschendorff AE, Rakyan VK, Maxwell AP, Beck S, Savage DA. Genome-wideDNAmethylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics. 2010;3:33.
19. Rakyan VK, Beyan H, Down TA, et al. Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet. 2011;7(9):e1002300.
20. Watabe K, Fukuda T, Tanaka J, Honda H, Toyohara K, Sakai O. Spontaneously immortalized adult mouse Schwann cells secrete autocrine and paracrine growth-promoting activities. J Neurosci Res. 1995;41(2):279-290.
21. Sango K, Suzuki T, Yanagisawa H, et al. High glucose-induced activation of the polyol pathway and changes of gene expression profiles in immortalized adult mouse Schwann cells IMS32. J Neurochem. 2006;98(2):446-458.
22. Sango K, Yanagisawa H, Takaku S, Kawakami E, Watabe K. Immortalized adult rodent Schwann cells as in vitro models to study diabetic neuropathy. Exp Diabetes Res. 2011;2011:374943.
23. Phillips LS, Olson DE. Diabetes: normal glucose levels should be the goal. Nat Rev Endocrinol. 2012;8(9):510-512.
24. PoplawskiMM,Mastaitis JW, Yang XJ, Mobbs CV. Hypothalamic responses to fasting indicate metabolic reprogramming away from glycolysis toward lipid oxidation. Endocrinology. 2010;151(11): 5206-5217.
25. Dreszer TR, Karolchik D, Zweig AS, et al. The UCSC Genome Browser database: extensions and updates 2011. Nucleic Acids Res. 2012;40(Database issue):D918-D923.
26. Filosa S, Fico A, Paglialunga F, et al. Failure to increase glucose consumption through the pentose-phosphate pathway results in the death of glucose-6-phosphate dehydrogenase gene-deleted mouse embryonic stem cells subjected to oxidative stress. Biochem J. 2003; 370(Pt 3):935-943.
27. El Boghdady NA, Badr GA. Evaluation of oxidative stress markers and vascular risk factors in patients with diabetic peripheral neuropathy. Cell Biochem Funct. 2012;30(4):328-334.
28. Russell JW, Berent-Spillson A, Vincent AM, Freimann CL, Sullivan KA, Feldman EL. Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol Dis. 2008;30(3):420-429.
29. Rö sen P, Nawroth PP, King G, Mö ller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes-Metab Res Rev. 2001;17(3):189-212.
30. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615-1625.
31. Ido Y. Pyridine nucleotide redox abnormalities in diabetes. Antioxid Redox Signal. 2007;9(7):931-942.
32. Williamson JR, Chang K, Frangos M, et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 1993;42(6):801-813.
33. Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol. 1994;266(6 Pt 2):H2568-H2572.
34. Matschinsky FM, Pagliara AS, Stillings SN, Hover BA. Glucose and ATPlevels in pancreatic islet tissue of normal and diabetic rats. J Clin Invest. 1976;58(5):1193-1200.
35. Zhang L,YuC, Vasquez FE, et al. Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production. J Proteome Res. 2010;9(1): 458-471.
36. Chowdhury SK, Smith DR, Fernyhough P. The role of aberrant mitochondrial bioenergetics in diabetic neuropathy. Neurobiol Dis. 2013;51:56-65.
37. Pellerin L, Pellegri G, Bittar PG, et al. Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev Neurosci. 1998;20(4-5):291-299.
38. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR-γ). J Biol Chem. 1995;270(22):12953-12956.
39. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study [published correction appears in Lancet. 2001; 357(9271):1890]rsqb]. Lancet. 2001;357(9260):905-910.
40. Venä läinen T, Molnár F, Oostenbrink C, Carlberg C, Peräkylä M. Molecular mechanism of allosteric communication in the human PPARα -RXRα heterodimer. Proteins. 2010;78(4):873-887.
41. Yamazaki T, Shiraishi S, Kishimoto K, Miura S, Ezaki O. An increase in liver PPARγ 2 is an initial event to induce fatty liver in response to a diet high in butter:PPARγ 2 knockdown improves fatty liver induced by high-saturated fat. J Nutr Biochem. 2011;22(6): 543-553.
42. Thompson RF, Atzmon G, Gheorghe C, et al. Tissue-specific dysregulation of DNA methylation in aging. Aging Cell. 2010;9(4): 506-518.
43. Askwith T, Zeng W, Eggo MC, Stevens MJ. Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy. Am J Physiol Endocrinol Metab. 2009;297(3):E620-E628.
44. Obrosova IG, Drel VR, Pacher P, et al. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes. 2005; 54(12):3435-3441.
45. Schmeichel AM, Schmelzer JD, Low PA. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes. 2003;52(1):165-171.
46. Salvemini F, Franze A, Iervolino A, Filosa S, Salzano S, Ursini MV. Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression. J Biol Chem. 1999;274(5):2750- 2757.
47. D'Souza B, D'Souza V, Sowmya S, et al. A comparative study on oxidative stress and antioxidant status in ischemic stroke patients with and without diabetes. Indian J Clin Biochem: IJCB. 2008; 23(3):218-222.
48. Rizzardini M, Lupi M, Bernasconi S, Mangolini A, Cantoni L. Mitochondrial dysfunction and death in motor neurons exposed to the glutathione-depleting agent ethacrynic acid. J Neurol Sci. 2003; 207(1-2):51-58.
49. Akhileshwar V, Patel SP, Katyare SS. Diabetic cardiomyopathy and reactive oxygen species (ROS) related parameters in male and female rats:Acomparative study. Indian J Clin Biochem: IJCB. 2007;22(1): 84-90.
50. Ceriello A, Giacomello R, Stel G, et al. Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress. Diabetes. 1995;44(8):924-928.
51. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, et al. PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 1996; 15(19):5336-5348.
52. Liu X, Wang X, Zhang J, et al. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. Oncogene. 2010;29(3):442-450.
53. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012;13(7):484-492.
54. Eckersley L. Role of the Schwann cell in diabetic neuropathy. Int Rev Neurobiol. 2002;50:293-321.
55. Viader A, Golden JP, Baloh RH, Schmidt RE, Hunter DA, Milbrandt J. Schwann cell mitochondrial metabolism supports longterm axonal survival and peripheral nerve function. J Neurosci. 2011;31(28):10128-10140.
56. Verheijen MH, Chrast R, Burrola P, Lemke G. Local regulation of fat metabolism in peripheral nerves. Genes Dev. 2003;17(19): 2450-2464.